DNAprint Genomics (DNAG)

[DorseyE]

Press Release Source: DNAPrint genomics, Inc.

DNAPrint Teams With Victoria Police Forensic Services Center to Win Australian ISL Grant
Thursday February 10, 8:30 am ET

SARASOTA, Fla., Feb. 10 /PRNewswire-FirstCall/ -- DNAPrint genomics (OTC Bulletin Board: DNAP - News; the "Company") announces today that it has teamed with Victoria University in Melbourne, Australia and the Victoria Police Forensic Science Services Centre (VFSC) to win a highly competitive 2004 Australian International Science Linkages (ISL) grant.

ADVERTISEMENT
The grant was authored by Victoria University's Dr. Swati Baindur-Hudson, with the assistance of DNAPrint scientists, to support the validation and potential integration of the Company's RETINOME(TM) test at the VFSC. The ISL program supports Australian scientists, from both the public and private sectors, to collaborate with international partners on leading-edge science and technology in order to contribute to Australia's economic, social and environmental wellbeing.

The subject of the grant, DNAPrint's RETINOME(TM) test, is a genetic assay for the inference of iris color from DNA. When used with other DNAPrint products for the inference of continental (DNAWitness(TM) 2.5) and ethno geographic ancestry (EUROWITNESS(TM) 1.0), it allows law enforcement to "paint" physical profiles from crime-scene DNA specimens and thereby to augment or substitute for unavailable or incomplete human eye-witness testimony.

The RETINOME(TM) assay functions by measuring multiple genetic variants called Single Nucleotide Polymorphisms (SNPs), located in regions of the human genome that are involved in pigment production. The test is the first commercially available "complex" genetics test to have been developed from the knowledge provided by the recently completed human genome sequencing project. Complex genetics tests have heretofore been notoriously difficult to develop, in part because their determination is the byproduct of multiple, interacting genes and their expression is usually quantitative rather than discrete (i.e. black/white). DNAPrint's development of innovative genome screening techniques and analytical methods enabled it to launch a service version of the test last August.

Customers can learn more about DNAPrint's tests for the inference of physical characteristics from DNA through email ([e-mail]), the Company's websites (http://www.dnaprint.com, http://www.ancestrybydna.com) or telephone [phone]).

About DNAPrint genomics, Inc.

DNAPrint genomics Inc. uses proprietary human genome research methods to develop genomic-based services and products. The Company introduced ANCESTRYbyDNA(TM) in the consumer market and DNAWitness(TM) in the forensic market in 2003. DNAPrint is developing products in the pharmacogenomic market and has a disease gene discovery program. The Company is traded on the NASDAQ OTC Bulletin Board under the ticker symbol: DNAP. For more information about the company, please visit http://www.dnaprint.com .

About Victoria University, Australia

Victoria University, one of the largest universities in Australia, has a number of areas of research strengths that match the needs and interests of existing and potential external stakeholders. The University focuses on mission-oriented research that is relevant to the needs of society. Its staff has worked extensively in collaborative projects with industry and government organizations, one of them being the Victoria Police Forensic Service Center.

About the Victoria Police Forensic Service Center

The biology division of the Victoria Forensic Service Center provides high quality biological scientific/technical services to Victoria Police and clients and comprises three branches, the Botany Branch, the Biological Examination Branch and the DNA Analysis Branch. The DNA Science Branch is recognized as one of Australia's most forward-thinking and innovative molecular forensic laboratories.

All statements in this press release that are not historical are forward- looking statements. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including, but not limited to, uncertainties relating to technologies, product development, manufacturing, market acceptance, cost and pricing of DNAPrint's products, dependence on collaborations and partners, regulatory approvals, competition, intellectual property of others, and patent protection and litigation. DNAPrint genomics, Inc. expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward- looking statements contained herein to reflect any change in DNAPrint's expectations with regard thereto or any change in events, conditions, or circumstances on which any such statements are based.

Media and Press Contacts
Richard Gabriel
DNAPrint Genomics, Inc.
CEO/President
[phone]



------------------------------------------------------------------------
Source: DNAPrint genomics, Inc.